Abstract
Btn2p, a novel coiled-coil protein, is up-regulated in btn1delta yeast strains, and this up-regulation is thought to contribute to maintaining a stable vacuolar pH in btn1delta strains (D. A. Pearce, T. Ferea, S. A. Nosel, B. Das, and F. Sherman, Nat. Genet. 22:55-58, 1999). We now report that Btn2p interacts biochemically and functionally with Rsglp, a down-regulator of the Can1p arginine and lysine permease. Rsglp localizes to a distinct structure toward the cell periphery, and strains lacking Btn2p (btn2delta strains) fail to correctly localize Rsg1p. btn2delta strains, like rsg1delta strains, are sensitive for growth in the presence of the arginine analog canavanine. Furthermore, btn2delta strains, like rsg1delta strains, demonstrate an elevated rate of uptake of [14C]arginine, which leads to increased intracellular levels of arginine. Overexpression of BTN2 results in a decreased rate of arginine uptake. Collectively, these results indicate that altered levels of Btn2p can modulate arginine uptake through localization of the Can1p-arginine permease regulatory protein, Rsglp. Our original identification of Btn2p was that it is up-regulated in the btn1delta strain which serves as a model for the lysosomal storage disorder Batten disease. Btnlp is a vacuolar/lysosomal membrane protein, and btn1delta suppresses both the canavanine sensitivity and the elevated rate of uptake of arginine displayed by btn2delta rsg1delta strains. We conclude that Btn2p interacts with Rsglp and modulates arginine uptake. Up-regulation of BTN2 expression in btn1delta strains may facilitate either a direct or indirect effect on intracellular arginine levels.
MeSH Terms
Arginine/metabolism
Base Sequence
Biological Transport, Active
DNA, Fungal/genetics
Humans
Lysosomes/metabolism
Membrane Glycoproteins
Models, Biological
Molecular Chaperones
Neuronal Ceroid-Lipofuscinoses/etiology,genetics,metabolism
Proteins/genetics,metabolism
Saccharomyces cerevisiae/genetics,growth & development,metabolism
Saccharomyces cerevisiae Proteins/genetics,metabolism
Vacuoles/metabolism
Chemicals
CLN3 protein, human
DNA, Fungal
Membrane Glycoproteins
Molecular Chaperones
Proteins
Saccharomyces cerevisiae Proteins
Arginine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Chattopadhyay Subrata
Center for Aging and Developmental Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.
Pearce David A
References (21)
21 references, click to expand
-
The Saccharomyces cerevisiae Rheb G-protein is involved in regulating canavanine resistance and arginine uptake.
J Biol Chem. 2000 Apr 14;275(15):11198-206
PMID: 10753927
-
Batten disease: evaluation of CLN3 mutations on protein localization and function.
Hum Mol Genet. 2000 Mar 22;9(5):735-44
PMID: 10749980
-
Changes induced in the permeability barrier of the yeast plasma membrane by cupric ion.
J Bacteriol. 1988 Jun;170(6):2676-82
PMID: 3286617
-
Mutants of Saccharomyces cerevisiae with defective vacuolar function.
J Bacteriol. 1988 Jun;170(6):2687-91
PMID: 3131305
-
Lysosomal storage of subunit c of mitochondrial ATP synthase in Batten's disease (ceroid-lipofuscinosis).
Biochem J. 1991 Apr 1;275 ( Pt 1):269-72
PMID: 1826833
-
Specific storage of subunit c of mitochondrial ATP synthase in lysosomes of neuronal ceroid lipofuscinosis (Batten's disease).
J Biochem. 1992 Feb;111(2):278-82
PMID: 1533218
-
Evidence for lipase abnormality: high levels of free and triacylglycerol forms of unsaturated fatty acids in neuronal ceroid-lipofuscinosis tissue.
Am J Med Genet. 1992 Feb 15;42(4):549-54
PMID: 1609837
-
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease).
Am J Med Genet. 1992 Feb 15;42(4):561-7
PMID: 1535179
-
Batten disease and the ATP synthase subunit c turnover pathway: raising antibodies to subunit c.
Am J Med Genet. 1995 Jun 5;57(2):260-5
PMID: 7668342
-
Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.
Cell. 1995 Sep 22;82(6):949-57
PMID: 7553855
-
The neuronal ceroid-lipofuscinoses.
J Child Neurol. 1995 Nov;10(6):424-37
PMID: 8576551
-
BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase.
Yeast. 1997 Jun 30;13(8):691-7
PMID: 9219333
-
Hsp30, the integral plasma membrane heat shock protein of Saccharomyces cerevisiae, is a stress-inducible regulator of plasma membrane H(+)-ATPase.
Cell Stress Chaperones. 1997 Mar;2(1):12-24
PMID: 9250391
-
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
Hum Mol Genet. 1998 Jan;7(1):85-90
PMID: 9384607
-
A yeast model for the study of Batten disease.
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6915-8
PMID: 9618513
-
Intracellular distribution of amino acids in an slp1 vacuole-deficient mutant of the yeast Saccharomyces cerevisiae.
J Appl Microbiol. 1998 May;84(5):752-8
PMID: 9674128
-
The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease.
Biochem Biophys Res Commun. 1998 Sep 18;250(2):335-41
PMID: 9753630
-
Action of BTN1, the yeast orthologue of the gene mutated in Batten disease.
Nat Genet. 1999 May;22(1):55-8
PMID: 10319861
-
Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL)
Hum Mol Genet. 1999 Jun;8(6):1091-8
PMID: 10332042
-
Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
J Neurosci Res. 2000 Jan 1;59(1):19-23
PMID: 10658181
-
The yeast model for batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis.
J Bacteriol. 2000 Nov;182(22):6418-23
PMID: 11053386